Details of the Drug
General Information of Drug (ID: DMHYQ3Z)
Drug Name |
3-benzyl-5-methylbenzo[d]oxazol-2(3H)-one
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
3-Benzyl-5-methyl-3H-benzooxazol-2-one; CHEMBL523238; 3-benzyl-5-methylbenzo[d]oxazol-2(3H)-one; F1633-0044; 107235-17-6; AC1LLOHB; BAS 07089306; MLS001205717; SCHEMBL10874258; MolPort-000-473-697; ZINC806272; HMS2816L07; BDBM50265523; ZINC 00806272; AKOS000649124; MCULE-9514588723; CCG-142613; SMR000523953; 3-benzyl-5-methyl-1,3-benzoxazol-2-one; 5-methyl-3-benzyl-3-hydrobenzoxazol-2-one
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 239.27 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 3.2 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 0 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||